Oil

Oil
Oil

US PPI rises less than expected on stable service costs

US producer prices increased less than expected in March, as stable service costs helped offset a sharp rise in energy prices triggered by the ongoing war with Iran. The Producer Price Index (PPI) for final demand rose 0.5% last month, matching a downwardly revised increase in February, data from the Bureau of Labor Statistics showed

Read More
Oil

UK shares rise as US-Iran peace talk hopes boost sentiment

UK equities moved higher on Tuesday, supported by optimism around potential US-Iran negotiations, even as geopolitical tensions remained elevated with the United States initiating a blockade of Iran’s ports. The benchmark FTSE 100 index rose 0.1% to 10,593.65 points by 5:58 GMT. The mid-cap FTSE 250 outperformed, climbing 1.13%. The gains reflected broader strength across

Read More
Oil

Dow Jones rises as Iran talk hopes lift stocks, earnings in focus

Wall Street opened higher on Tuesday as renewed hopes of diplomatic progress in the Middle East lifted investor sentiment, even as markets digested fresh corporate earnings and softer-than-expected inflation data. The S&P 500 rose 0.39%, while the Dow Jones Industrial Average added about 45 points or 0.09%. Nasdaq-100 climbed 0.76%, extending momentum from the previous

Read More
Oil

MYX Finance token surges to $0.599 before sharp pullback: what next

The MYX Finance (MYX) cryptocurrency has had one of those days that instantly grabs attention in the crypto market. The token surged aggressively, briefly touching a high of $0.599 before sliding back down to around $0.3208. Moves like this are not just random spikes; they usually reflect a mix of strong speculation, heavy trading activity,

Read More
Oil

Nvidia stock rises for 10th day: what’s behind the recent strength

Nvidia shares rose on Tuesday, putting the stock on track for a 10th consecutive session of gains. At the time of writing, the Nvidia stock was up 1.6% to trade around $192. The move was supported by a broader market rally. The S&P 500 gained 0.4%, while the Dow Jones Industrial Average added 158 points,

Read More
Oil

IMF cuts UK, Germany growth forecasts on energy shock from Iran conflict

The International Monetary Fund has sharply downgraded economic growth forecasts for both the United Kingdom and Germany, citing the inflationary fallout from the Iran conflict. Britain recorded the steepest downgrade among major advanced economies. The IMF now expects the UK economy to grow by 0.8% in 2026, down from its earlier projection of 1.3%. UK

Read More
Oil

Wells Fargo stock slips on NII miss: can growth offset rate pressure?

Shares of Wells Fargo fell on Tuesday after the lender reported first-quarter net interest income that came in below Wall Street expectations, highlighting the near-term pressure from lower interest rates even as broader fundamentals remained stable. The stock dropped about 4.9% following the results, extending its year-to-date decline to roughly 13%. The reaction came despite

Read More
Oil

US-Iran peace talks fail: what’s next for VanEck Semiconductor ETF (SMH)

The VanEck Semiconductor ETF (SMH) is in sharp focus on Apr. 13 after the high-stakes US-Iran peace talks collapsed, dashing hopes of a diplomatic resolution in the Middle East. SMH is now flashing technical caution as its relative strength index (RSI) hovers in the late 60s, a level that suggests the asset is rapidly approaching

Read More
Oil

Intel stock is in a parabolic move, and a rare pattern points to a surge to $82

Intel stock price has staged a strong comeback this year and is now hovering near its all-time high. It soared to $62.40, up by over 245% from its lowest level last year, bringing its market capitalization to over $313 billion. Intel stock has soared as numerous catalysts converged INTC stock has rebounded in the past

Read More
Oil

Revolution Medicines surges 38% on pancreatic cancer breakthrough

Shares of Revolution Medicines surged sharply on Monday after the company reported positive results from a late-stage trial of its experimental pancreatic cancer drug, raising hopes for a potential breakthrough in one of the deadliest forms of the disease. The stock climbed 38% after the opening bell, extending gains to 69% since the start of

Read More